Newton, MA, United States of America

Nicole Cohen

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Dana-Farber-Cancer Institute Inc.. Active years: 2018.

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Inventor Nicole Cohen

Introduction

Nicole Cohen is a prominent inventor based in Newton, MA (US). She has made significant contributions to the field of biomedical research, particularly in the modulation of cell death and related disorders. Her work focuses on developing small molecules that can selectively bind to the survival protein MCL-1, which plays a crucial role in various cellular processes.

Latest Patents

Nicole Cohen holds a patent for "Small molecules for the modulation of MCL-1 and methods of modulating cell death, cell division, cell differentiation and methods of treating disorders." This invention relates to compounds that selectively bind to MCL-1 with high affinity and selectivity. The pharmaceutical compositions containing these compounds are designed for modulating MCL-1 activity and treating various disorders, including hyperproliferative disorders, angiogenesis disorders, and inflammatory disorders. The compounds can be used as a sole agent or in combination with other active ingredients to enhance cellular engraftment and wound repair.

Career Highlights

Nicole Cohen is affiliated with the Dana-Farber Cancer Institute Inc., where she continues her research and development efforts. Her innovative work has the potential to impact the treatment of several serious health conditions, making her a valuable asset in the field of cancer research.

Collaborations

Nicole has collaborated with notable colleagues, including Loren D. Walensky and Michelle L. Stewart. These partnerships have furthered her research and contributed to the advancement of therapeutic strategies targeting MCL-1.

Conclusion

Nicole Cohen's contributions to the field of biomedical research through her innovative patent on MCL-1 modulation highlight her role as a leading inventor. Her work not only advances scientific understanding but also holds promise for developing new treatments for various disorders.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…